These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34965642)

  • 1. Relationship between montelukast and behavioral problems in preschool children with asthma.
    Özata E; Akelma Z; Günbey S
    Allergol Immunopathol (Madr); 2022; 50(1):85-91. PubMed ID: 34965642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
    Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
    Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions affecting treatment adherence in first-line treatment of asthma: An observational study.
    Erdem SB; Nacaroglu HT; Can D
    Allergol Immunopathol (Madr); 2023; 51(2):11-16. PubMed ID: 36916083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding.
    Apata J; Lyons JG; Bradley MC; Ma Y; Kempner ME; Kim I; Eworuke E; Pennap D; Mosholder A
    J Asthma; 2024 Jul; 61(7):653-662. PubMed ID: 38064517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on leukotriene receptor antagonists in preschool children wheezing disorders.
    Montella S; Maglione M; De Stefano S; Manna A; Di Giorgio A; Santamaria F
    Ital J Pediatr; 2012 Jun; 38():29. PubMed ID: 22734451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
    Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
    Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China.
    Chen ZM; Zhao DY; Xiang L; Hong JG
    World J Pediatr; 2021 Dec; 17(6):619-625. PubMed ID: 34613593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
    Szefler SJ; Carlsson LG; Uryniak T; Baker JW
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
    Hoshino M; Akitsu K; Ohtawa J
    J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
    [No Abstract]   [Full Text] [Related]  

  • 16. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of step-down therapy from an inhaled steroid to montelukast in childhood asthma.
    Ciółkowski J; Mazurek H; Stasiowska B
    Allergol Immunopathol (Madr); 2014; 42(4):282-8. PubMed ID: 23684855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.
    Stempel DA; O'Donnell JC; Meyer JW
    J Allergy Clin Immunol; 2002 Mar; 109(3):433-9. PubMed ID: 11897987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
    Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
    Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.
    Xu Z; Meng L; Xie Y; Guo W
    Braz J Med Biol Res; 2020; 53(7):e9271. PubMed ID: 32520202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.